Earnings

Edesa Biotech Q3 EPS $(0.60) Misses $(0.58) Estimate

Aug 13, 2026 · 04:45 PM ET· updated 3h ago

Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.58) by 3.45 percent. This is a 140 percent decrease over losses of $(0.25) per share from the

Why It Matters

Edesa Biotech lost more money per share than experts thought it would, and its losses got way bigger compared to last year. When a company's losses grow like this, it's worth watching to see if they have a plan to turn things around.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

EDSA5.61

+0.31 (+5.92%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.